TIGAR, a p53-inducible regulator of glycolysis and apoptosis

被引:1584
作者
Bensaad, Karim
Tsuruta, Atsushi
Selak, Mary A.
Calvo Vidal, M. Nieves
Nakano, Katsunori
Bartrons, Ramon
Gottlieb, Eyal
Vousden, Karen H.
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, Lhospitalet De Llobregat 08907, Spain
关键词
D O I
10.1016/j.cell.2006.05.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The, p53 tumor-suppressor protein prevents cancer development through various mechanisms, including the induction of cell-cycle arrest, apoptosis, and the maintenance of genome stability. We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels. These functions of TIGAR correlated with an ability to protect cells from ROS-associated apoptosis, and consequently, knockdown of endogenous TIGAR expression sensitized cells to p53-induced death. Expression of TIGAR may therefore modulate the apoptotic response to p53, allowing survival in the face of mild or transient stress signals that may be reversed or repaired. The decrease of intracellular ROS levels in response to TIGAR may also play a role in the ability of p53 to protect from the accumulation of genomic damage.
引用
收藏
页码:107 / 120
页数:14
相关论文
共 43 条
[21]   Cellular response to oxidative stress: Signaling for suicide and survival [J].
Martindale, JL ;
Holbrook, NJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 192 (01) :1-15
[22]   A ribonucleotide reductase gene is a transcriptional target of p53 and p73 [J].
Nakano, K ;
Bálint, É ;
Ashcroft, M ;
Vousden, KH .
ONCOGENE, 2000, 19 (37) :4283-4289
[23]   FRUCTOSE 2,6-BISPHOSPHATE METABOLISM IN EHRLICH ASCITES TUMOR-CELLS [J].
NISSLER, K ;
PETERMANN, H ;
WENZ, I ;
BROX, D .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (12) :739-745
[24]   PFK-2/FBPase-2:: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate [J].
Okar, DO ;
Manzano, A ;
Navarro-Sabatè, A ;
Riera, L ;
Bartrons, R ;
Lange, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :30-35
[25]   Kinetic properties of human placental glucose-6-phosphate dehydrogenase [J].
Özer, N ;
Aksoy, Y ;
Ögüs, IH .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (03) :221-226
[26]   Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression [J].
Perez, JX ;
Roig, T ;
Manzano, A ;
Dalmau, M ;
Boada, J ;
Ventura, F ;
Rosa, JL ;
Bermudez, J ;
Bartrons, R .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (05) :C1359-C1365
[27]   A model for p53-induced apoptosis [J].
Polyak, K ;
Xia, Y ;
Zweier, JL ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1997, 389 (6648) :300-305
[28]   Genetic determinants of p53-induced apoptosis and growth arrest [J].
Polyak, K ;
Waldman, T ;
He, TC ;
Kinzler, KW ;
Vogelstein, B .
GENES & DEVELOPMENT, 1996, 10 (15) :1945-1952
[29]   Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant [J].
Rowan, S ;
Ludwig, RL ;
Haupt, Y ;
Bates, S ;
Lu, X ;
Oren, M ;
Vousden, KH .
EMBO JOURNAL, 1996, 15 (04) :827-838
[30]   The antioxidant function of the p53 tumor suppressor [J].
Sablina, AA ;
Budanov, AV ;
Ilyinskaya, GV ;
Agapova, LS ;
Kravchenko, JE ;
Chumakov, PM .
NATURE MEDICINE, 2005, 11 (12) :1306-1313